Três casos de miosite induzida pelo anti‐TNF e revisão da literatura

Reimold, 2003, New indications for treatment of choronic inflammation by TNF‐alpha blockade, Am J Med Sci., 325, 75, 10.1097/00000441-200302000-00005 Kochbati, 2004, TNF alfa modulators in the treatment of RA, Tunis Med., 82, 893 Ishikawa, 2010, Etanercept‐induced anti‐Jo‐1‐antibody‐positive polymyositis in a patient with RA: a case report and review of the literature, Clin Rheumatol., 29, 563, 10.1007/s10067-009-1370-1 Musial, 2003, Polymyositis associated with infliximab treatment for RA, Rheumatology (Oxford), 42, 1566, 10.1093/rheumatology/keg388 Flendrie, 2003, Survival during treatment with tumour necrosis factor blocking agents in RA, Ann of the Rheum Dis., 62, 30 Flendrie, 2005, Dermatological conditions during TNF‐alpha‐blocking therapy in patients with RA: a prospective study, Arth Res & Ther., 7, R666, 10.1186/ar1724 Urata, 2006, Polymyositis associated with infliximab treatment for RA, Mod Rheumatol., 16, 410, 10.3109/s10165-006-0523-1 Hall, 2006, Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor, Arthritis & Rheum., 55, 982, 10.1002/art.22358 Liozon, 2007, Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma, Scand Jour of Rheum., 36, 484, 10.1080/03009740701281293 Kiltz, 2008, Neuromuscular involvement in rheumatic patients treated with anti‐TNF therapy—three examples, J Rheum., 35, 2074 Ramos-Casals, 2008, Autoimmune diseases induced by TNF targeted therapies, Best Prac and Res., 22, 847, 10.1016/j.berh.2008.09.008 Brunasso, 2010, Dermatomyositis during adalimumab therapy for RA, Jour of Rheum., 37, 1549, 10.3899/jrheum.091413 Klein, 2010, Tumor necrosis factor inhibitor‐associated dermatomyositis, Archives of Dermatology, 146, 780, 10.1001/archdermatol.2010.142 Ishiguro, 2010, Antisynthetase (anti PL‐7 antibody) syndrome presenting as a skin rash and exacerbation of interstitial pneumonia during treatment for RA, Nihon Kokyuki Gakkai Zasshi, 48, 240 Ishikawa, 2011, A case of antisynthetase syndrome in a RA patient with anti‐PL‐12 antibody following treatment with etanercept, Clin Rheumatol., 30, 429, 10.1007/s10067-010-1666-1 Riolo, 2012, Anti‐tumor necrosis factor inhibitor therapy‐induced dermatomyositis and fasciitis, Jour of Rheum., 39, 192 Liu, 2013, Dermatomyositis induced by anti‐tumor necrosis factor in a patient with juvenile idiopathic arthritis, JAMA Dermatol., 149, 1204, 10.1001/jamadermatol.2013.5220 Zampieri, 2005, Anti‐Jo‐1 antibodies, Autoimmunity, 38, 73, 10.1080/08916930400022640 Ascherman, 2003, The role of Jo‐1 in the immunopathogenesis of polymyositis: current hypotheses, Curr Rheumatol Rep., 5, 425, 10.1007/s11926-003-0052-2 Moran, 2014, Cytokines in immune mediated inflammatory myopathies: cellular sources, multipl actions and therapeutic implications, Clin Exp Immunol, 178, 405, 10.1111/cei.12445 Marie, 2011, Therapy of polimyositis and dermatomyositis, Presse Med., 40, e257, 10.1016/j.lpm.2010.12.012 Tournadre, 2010, Treatment of inflammatory muscle disease in adults, Joint Bone Spine, 77, 390, 10.1016/j.jbspin.2010.04.007 Ramos-Casals, 2007, Autoimmune diseases induced by TNF‐targeted therapies: analysis of 233 cases, Medicine (Baltimore), 86, 242, 10.1097/MD.0b013e3181441a68 Iannone, 2006, Use of etanercept in the treatment of dermatomyositis: a case series, J Rheumatol., 33, 1802 St Clair, 2002, The relationship of serum infliximab concentrations to clinical improvement in RA: results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trial, Arthritis Rheum., 46, 1451, 10.1002/art.10302 Aguila, 2014, Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or RA, Clin Rheumatol., 33, 1093, 10.1007/s10067-014-2730-z Efthimiou, 2006, Tumor necrosis factor‐α in inflammatory myopathies: pathophysiology and therapeytic implications, Semin Arthritis Rheum., 36, 168, 10.1016/j.semarthrit.2006.07.003